|Bid||2.1500 x 4000|
|Ask||0.0000 x 3100|
|Day's range||2.1950 - 2.2600|
|52-week range||1.3300 - 4.6800|
|Beta (5Y monthly)||2.03|
|PE ratio (TTM)||101.36|
|Earnings date||13 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||7.00|
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Accuray's (ARAY) newly launched CyberKnife S7 System will enable clinicians to provide best possible care to their patients through new capabilities.
Since the coronavirus outbreak, robots have filled up several job vacancies caused by social distancing orders. Here are five robotics and related stocks investors should closely watch.
Joshua Levine has been the CEO of Accuray Incorporated (NASDAQ:ARAY) since 2012. This report will, first, examine the...
Shareholders will be ecstatic, with their stake up 24% over the past week following Accuray Incorporated's...
Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Accuray (ARAY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Welcome to Accuray's conference call to review financial results for the third quarter of fiscal year 2020, which ended March 31, 2020. Joining us today are Josh Levine, Accuray's President and Chief Executive Officer; and Shig Hamamatsu, Accuray's Senior Vice President and Chief Financial Officer.
Accuray Incorporated's (NASDAQ:ARAY): Accuray Incorporated designs, develops, and sells radiosurgery and radiation...
Change Healthcare's (CHNG) third-quarter fiscal earnings benefit from solid performance across the segments - Software and Analytics and Network Solutions. However, decline in revenues remains a woe.
The Zacks Analyst Blog Highlights: Accuray, MagnaChip Semiconductor, Rite Aid, Vericel and RGC Resources
U.S. stocks are heavily exposed to the domestic economy where data continues to improve. And even if skeptics worry about the virus outbreak, developed markets are more stable than emerging markets during chaotic times.
Luminex's (LMNX) fourth-quarter earnings benefit from higher revenues and solid performance across System Sales, Service and Other Revenues. However, gross margin contraction remains a woe.